Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, August 5 at 2:00 PM EDT

Register Free →

Fast Assessment of Solutions, Therapeutics, Pharmaceuticals, and SupplieS (FASTPASS) Proposer Workshop

Active
ARPA-H-SN-26-157Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The Advanced Research Projects Agency for Health is hosting a virtual Proposer Workshop to support an anticipated Innovative Solution Opening under the FASTPASS program, which aims to rapidly assess solutions, therapeutics, pharmaceuticals, and supplies. This event is intended to guide potential applicants through the solicitation process and provide clarity on expectations for proposals targeting agile, scalable innovations in health security and medical response. The workshop is tied to Special Notice ARPA-H-SN-26-157, issued on July 28, 2026, with a response deadline of August 20, 2026, at 4:00 p.m. Eastern Time. Interested parties should register and participate virtually to prepare for the upcoming competitive opportunity. The solicitation falls under NAICS code 541715 and is administered by the Scalable Solutions Office within ARPA-H, a component of the U.S. Department of Health and Human Services, based in Washington, D.C. All submissions and communications must align with the official guidelines outlined in the attached notice, and no set-aside provisions are specified for this opportunity.

General Info

ARPA-H hosts virtual workshop for FASTPASS solicitation on health innovations with August 20, 2026 deadline.

Agency

Department Of Health And Human Services → Advanced Research Projects Agency For Health (arpa-H)View Agency

NAICS

541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)View NAICS

Place of Performance

DC, 20005, USA

Set-Aside

NONE

Documents

(1)

SN-ARPA-H-26-157_FASTPASS.pdf

PDF

AI Contract Breakdown

Uniform Contract Format

What is UCF?

Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.

Timeline

Posted

special-notice

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → Advanced Research Projects Agency For Health (arpa-H)
ContactsNo contacts available
OfficeWashington, DC, 20005, USA
Organization / Agency
Department Of Health And Human Services → Advanced Research Projects Agency For Health (arpa-H)
View Agency Profile
Office AddressWashington, DC, 20005, USA
ContactsNo contact information available

Full Description

Show more

This Special Notice (SN) is intended to alert the scientific community that the Scalable Solutions Office (SSO) of the Advanced Research Projects Agency for Health is hosting a virtual Proposer Workshop in support of an anticipated Innovative Solution Openings (ISO) for the Fast Assessment of Solutions, Therapeutics, Pharmaceuticals, And SupplieS (FASTPASS) program.


See attached SN ARPA-H-SN-26-157_FASTPASS file for further details.

Similar Contracts

Same NAICS industry code

NAICS: 541715
New
Federal
Quantitative Decision Reliability of AI-Accelerated Computational Modeling and Simulation for Cardiovascular DevicesThe contract solicitation titled Quantitative Decision Reliability of AI-Accelerated Computational Modeling and Simulation for Cardiovascular Devices seeks proposals to advance the reliability and quantification of decision-making in cardiovascular device development through artificial intelligence-enhanced computational modeling and simulation. Submitted under solicitation number RFQ133983, this opportunity is issued by the FDA Office of Acquisition Grant Services within the Department of Health and Human Services and is open to qualified responders with technical expertise in AI, biomedical simulation, and regulatory science. Proposals must demonstrate the ability to develop methods that improve the confidence, reproducibility, and regulatory acceptance of computational outcomes used to support clinical and design decisions for cardiovascular devices. The response deadline is August 7, 2026, at 2:00 PM Eastern Time, with submissions due no later than that time. The NAICS code 541715 applies, indicating this solicitation focuses on research and development in the physical, engineering, and life sciences. There is no set-aside designation, meaning all eligible entities may compete. The contracting office is located in Rockville, Maryland, and Telisha Wilson serves as the primary point of contact for inquiries, reachable via email or phone provided in the solicitation.
FDA Office Of Acq Grant Svcs

POSTED

about 11 hours ago

DEADLINE

in 10 days
View Details
NAICS: 541715
New
Federal
Physiological Signal Dataset Development for AI/ML Wearable Device ResearchThe FDA Office of Acquisition Grant Services, under the Department of Health and Human Services, has issued a solicitation for the development of a physiological signal dataset to support artificial intelligence and machine learning research for wearable medical devices. The project requires the collection, processing, and annotation of high-quality physiological data from human subjects using wearable sensors, with the goal of creating a standardized, de-identified dataset usable for training and validating AI algorithms. The solicitation, identified by RFQ134632, was posted on July 28, 2026, with a response deadline of August 7, 2026, and carries a NAICS code of 541715 for research and development in the physical, engineering, and life sciences. The work is expected to be conducted in coordination with FDA standards for data privacy, quality, and ethical sourcing, and must comply with all applicable regulations governing human subject research and biomedical data handling. The primary point of contact for inquiries is Telisha Wilson, reachable via phone or email, and the office is located in Rockville, Maryland. There is no set-aside designation, meaning any eligible entity may respond regardless of size or ownership status. The place of performance is not specified, implying flexibility in where the data collection and processing may occur, provided all regulatory, ethical, and technical requirements are met. All proposals must demonstrate expertise in physiological signal acquisition, data annotation, AI/ML readiness, and compliance with federal guidelines for health data management. Successful bidders will be expected to deliver a fully documented, validated dataset with metadata and usage protocols suitable for integration into FDA-regulated AI/ML research pipelines.
FDA Office Of Acq Grant Svcs

POSTED

about 11 hours ago

DEADLINE

in 10 days
View Details
NAICS: 541715
New
Federal
PerrseusThe Defense Advanced Research Projects Agency (DARPA) is seeking innovative proposals under solicitation DARPA-PS-26-127, titled Perrseus, to advance the development of compact cold-atom devices and environmentally-decoupled ultra-high Q microelectromechanical (MEMS) and photonics systems through microscale ultra-high-vacuum (µUHV) technologies. This effort is structured as an Other Transaction (OT) agreement under 10 U.S.C. § 4022, bypassing traditional Federal Acquisition Regulation (FAR) processes to enable faster, more flexible collaboration with nontraditional defense contractors, academia, and small businesses. The award will be milestone-based, with payments tied to the successful completion of technical objectives defined in the performer’s proposal, and may follow a fixed-support or expenditure-based model depending on the negotiated structure. The program includes robust intellectual property provisions, where the government retains certain rights to inventions and data, while performers retain ownership, subject to specific obligations regarding practical application and record retention. Cybersecurity requirements mandate safeguarding covered defense information in accordance with CUI standards and require prompt reporting of cyber incidents, with applicable flow-down provisions to all subcontractors. Performance will be measured through periodic milestone reports reviewed by a DARPA Agreement Officer’s Representative, with electronic submission and acceptance handled via the Wide Area Workflow (WAWF) system. All awardees must be registered in the System for Award Management (SAM), maintain active Cage Code, UEI, and TIN data, and submit required certifications regarding tax compliance, felony convictions, and lobbying activities. A Data Management Plan must be submitted within 30 days of award via the DARPA Vault tool, and final deliverables include an executive summary, property reports for items over $10,000, and compliance with export control and telecommunications prohibitions. Proposals are due by September 23, 2026, and must be submitted via email with a password if necessary, while invention disclosures must be filed through I-Edison. The program emphasizes rapid prototyping, strict information control—prohibiting public dissemination without DARPA approval—and compliance with civil rights and national security mandates, including potential classification requirements if sensitive technologies are developed.
Defense Advanced Research Projects Agcy

POSTED

about 11 hours ago

DEADLINE

in about 2 months
View Details
NAICS: 541715
New
Federal
Technical Data and Software Delivery (Limited Rights)This contract pertains to the delivery of technical data, schematics, or restricted software under limited rights as defined by federal data rights clauses, specifying that the government's use, reproduction, or disclosure of the provided materials will be restricted to government purposes only. The subcontract is issued by Fermilab, a Department of Energy contractor, under NAICS code 541715, which categorizes it under research and development in the physical, engineering, and life sciences. Performance of the work is expected to occur in Batavia, with all deliverables subject to the limitations and protections outlined in applicable federal regulations governing proprietary or restricted technical information. The solicitation was posted on July 27, 2026, and responses are due by August 10, 2026, at 10:00 PM Eastern Time. While no set-aside provisions or specific organization type are designated, the nature of the contract requires strict adherence to federal data rights standards, ensuring that intellectual property rights of the contractor are preserved while granting the government only the minimal access necessary for operational or administrative use. The contracting office is not identified with a point of contact or full address, but the place of performance is confirmed to be in Batavia, indicating the physical or operational location where deliverables will be utilized or integrated.
Fermilab - DOE Contractor

POSTED

1 day ago

DEADLINE

in 13 days
View Details
NAICS: 541715
New
Federal
Biomechanical Data Collection (Motion Capture & EMG)The contract requires the conduct of biomechanical testing on eight to nine human participants using motion capture systems, force plates, and electromyography equipment to collect detailed kinematic, kinetic, and neuromuscular data. The work is part of a subcontract under the CDC Office of Acquisition Services within the Department of Health and Human Services and is classified under NAICS code 541715, indicating it involves research and development in the physical, engineering, and life sciences. The testing must be performed with precision to ensure high-quality data acquisition for scientific analysis, likely supporting public health research related to human movement or injury prevention. The solicitation was posted on July 27, 2026, with a hard deadline for responses at 4:00 PM on August 10, 2026. No set-aside type is specified, and no specific location is indicated for performance, suggesting the work may be conducted at the contractor’s facility or an agreed-upon site with appropriate instrumentation. The contract does not include a designated point of contact or detailed address information, implying correspondence and submission processes will be handled through the SAM.gov portal linked in the notice. All required equipment and participant recruitment must be managed by the contractor to meet the specifications outlined in the task scope.
CDC Office Of Acquisition Services

POSTED

1 day ago

DEADLINE

in 13 days
View Details
NAICS: 541715
New
Federal
CDRH Clinical Study Service ContractThe U.S. Food and Drug Administration’s Center for Devices and Radiological Health is soliciting commercial clinical study services under solicitation number 75F40126Q00193, with proposals due by August 4, 2026. The contract is a Firm Fixed Price (FFP) award for remote performance of a clinical study involving the collection, annotation, and delivery of 12-lead ECG data from 150 subjects in the base year and 35 subjects per optional year, alongside the development of a synthetic retrospective dataset of at least 4,000 subjects to support the validation of an FDA-developed ECG signal transformation framework for AI/ML-enabled cardiovascular devices. Performance is scheduled to begin September 30, 2026, with up to four one-year optional extensions through September 29, 2031. All deliverables, including approved study protocols, de-identified datasets, monthly progress reports, and a final public-ready dataset, must comply with FDA and IRB requirements, HIPAA standards for de-identification, and FDA-approved data collection procedures. The contract requires continuous monitoring of signal quality, synchronization of FDA-approved ECG devices, and collection of comprehensive metadata during resting, supine conditions. Offerors must demonstrate extensive experience in AI and machine learning applications for 10 or more years, a proven history analyzing wearable datasets, affiliation with a hospital within 10 miles of Silver Spring, Maryland, and a track record of conducting at least five clinical studies involving both healthy and unhealthy subjects, including publications in prestigious journals. Proposals must be submitted electronically via email to Natalie.Brown@fda.hhs.gov by the deadline, formatted into two volumes: a Technical Approach detailing methodology and personnel resumes, and a Price volume using the provided attached Price Sheet, which currently contains no populated values. All offerors must have an active UEI in SAM.gov, maintain compliance with employment eligibility, anti-trafficking, and cybersecurity regulations, and adhere to clauses covering whistleblower protections, subcontractor exclusions, paid sick leave, and data safeguarding. Payment must be processed exclusively through the U.S. Treasury’s Invoice Processing Platform, with no physical delivery or FOB terms applicable. The government will evaluate proposals based on technical merit and overall advantage, not solely on price, and will select the offeror best positioned to deliver high-quality, compliant clinical data under strict oversight. Security clearances are not required, but robust data protection measures
FDA Office Of Acq Grant Svcs

POSTED

1 day ago

DEADLINE

in 7 days
View Details
NAICS: 541715
New
Federal
3D Coastal Ocean Foundational Model Using AI, SCHISM and MLEOF Models.The National Oceanic and Atmospheric Administration’s Office of Coast Survey intends to award a sole-source purchase order to the Virginia Institute of Marine Science (VIMS) to develop an AI-based predictive model for ocean temperature, salinity, and currents by integrating the SCHISM physics-based modeling system and the MLEOF machine-learning empirical orthogonal function technique. VIMS is the sole originator and custodian of both the SCHISM model and its specialized 3D application, STOFS-3D-Atlantic, which provides the high-fidelity, long-term hindcast data essential for training the AI model. The project will further apply a generative forecasting transformer to derive accurate, deployable predictions, leveraging VIMS’s unique expertise in merging advanced coastal ocean modeling with proprietary AI methodologies that no other entity possesses. The agency determined no alternative sources exist due to the exclusive ownership of the required models and the deep, established technical integration capabilities only VIMS can provide, making competition infeasible. The contract period spans from October 1, 2026, to September 30, 2027, with no set-aside applied and the NAICS code 541715 assigned. Market research confirmed no other organizations can reproduce the necessary combination of SCHISM model access, MLEOF AI tool development, and operational-scale validation required to meet mission-critical objectives in coastal ocean prediction. While this is a presolicitation notice and not a competitive request, interested parties may submit supporting documentation or inquiries by August 11, 2026, to challenge the sole-source determination, though any decision to open competition remains at the government’s sole discretion. All communication must be in writing, and responses will be evaluated only to assess the validity of the sole-source justification. The place of performance is Gloucester Point, Virginia, with the primary point of contact being Michelle Walton of NOAA’s Eastern Acquisition Division in Norfolk.
Department Of Commerce Noaa

POSTED

1 day ago

DEADLINE

in 14 days
View Details
NAICS: 541715
New
Federal
Army Advanced Manufacturing (AdvM) Commercial Solutions Opening (CSO)The Army Advanced Manufacturing (AdvM) Commercial Solutions Opening (CSO), identified by solicitation number W9124P26SC001, is an ongoing, open solicitation managed by the Army Contracting Command – Redstone Arsenal to identify and acquire innovative commercial technologies that enhance manufacturing, maintenance, and sustainment capabilities across the Army’s Organic Industrial Base and at the tactical edge. This initiative leverages flexible acquisition authorities including 10 U.S.C. § 3458, § 4022, DFARS RFO 212.70, and the Employee Stock Ownership Pilot Program to support rapid prototyping and fielding of advanced manufacturing solutions in areas such as additive manufacturing, digital twins, Industrial Internet of Things, cybersecurity integration, and process qualification. Proposals are submitted through a two-phase process: Phase 1 requires a one-page Quad Chart and a five-page White Paper formatted in 12-point Times New Roman, single-spaced, with one-inch margins, submitted via email to the designated mailbox. While the CSO remains continuously open, specific Calls for Solutions will have defined deadlines, and only commercially available solutions meeting the defined Areas of Interest are considered. The Government retains the right to issue amendments, which will be highlighted in yellow for transparency, and does not guarantee that any Request for Information will lead to a follow-on opportunity. Award decisions are based on a best-value trade-off process, evaluating technical merit and relevance first, followed by innovation and uniqueness, company viability—including corporate experience, personnel qualifications, and data rights identification—and price and affordability. Non-cost factors collectively carry significantly more weight than cost, making this a non-LPTA process. All awards will be made as Firm-Fixed-Price contracts under DFARS RFO 212.7002(b), with potential award instruments including IDIQ contracts, Other Transaction Agreements, or direct purchase orders. Offerors must be registered in SAM.gov and hold an active Unique Entity ID, but no socioeconomic set-asides or size status certifications are mandated. Submission costs are not reimbursable, and proposals must comply with DFARS data rights clauses, particularly regarding intellectual property and technical data disclosure. Performance will be centered at Redstone Arsenal, Alabama, with operational delivery targeted to the OIB and tactical locations. No packaging, marking, or inspection standards are specified beyond the requirement that proposed solutions must demonstrate validated prototypes, qualified manufacturing processes, or commercialized technologies aligned with Army modernization priorities. The Government conducts all evaluation
W6QK Acc-Rsa

POSTED

1 day ago

DEADLINE

N/A
View Details

More opportunities from Department Of Health And Human Services → Advanced Research Projects Agency For Health (arpa-H)

Same awarding agency

NAICS: 541715
New
Federal
Hearing Enhancement through ARtificially Intelligent NeurotechnoloGy (HEARING)The Advanced Research Projects Agency for Health (ARPA-H) is issuing a solicitation under number ARPA-H-SOL-26-154 for the Hearing Enhancement through ARtificially Intelligent NeurotechnoloGy (HEARING) Program, targeting innovative neurotechnological solutions aimed at restoring hearing by intervening in the auditory cortex rather than the ear. The program seeks to develop a closed-loop system that records neural activity from the auditory cortex, dynamically modulates incoming sound in real time, and writes back missing auditory information through targeted stimulation. This effort is structured around three tightly integrated Technical Areas: TA1 involves creating minimally invasive intracortical devices with recording and stimulation capabilities; TA2 focuses on developing a wearable, wirelessly powered dynamic sound modulator; and TA3 requires designing real-time neurocomputational algorithms for decoding and encoding auditory signals, integrated with clinical neurology and audiology expertise. All three components must combine into a single, functional platform over a multi-phase development timeline with increasing complexity, with performance evaluated based on milestone achievement and intermediate metrics. Proposals must be submitted electronically via the ARPA-H Solution Submission Portal following strict formatting guidelines outlined in the solicitation's appendices. A mandatory solution summary, compliant with Appendix A, must be submitted prior to a full proposal, which must adhere to the structure in Appendix B and include supporting documents from Appendices C through F, including a cost proposal model and administrative policy template for Other Transactions. Cost submissions require justification for expenses above $15,000 with supporting documentation, and all proposals must include an updated Gantt chart reflecting project timelines. The solicitation mandates active SAM.gov registration, prohibits entities from covered foreign countries, foreign entities of concern, malign foreign talent recruitment participants, suspended or debarred firms, and federally funded research centers or government employees from participating as primes or subs. Proposers must comply with stringent data handling protocols for Controlled Unclassified Information, mark proprietary data clearly as “Proprietary” (not “Confidential”), and adhere to human and animal subject research regulations under 45 CFR § 46, 21 CFR § 56, 9 CFR parts 1–4, and the Public Health Service Policy. Invoicing must be processed through Payment Management Services with a standardized 1,000-character justification for each payment tied to accepted milestones. Evaluations prioritize scientific and technical merit, proposer capability, potential impact on ARPA-H’s mission, and cost realism, with awards expected to be issued
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

5 days ago

DEADLINE

in 17 days
View Details
NAICS: 541715
Federal
Restorative and health-Enhancing Sleep Time (REST)The Advanced Research Projects Agency for Health (ARPA-H) is soliciting innovative proposals under the Restorative and health-Enhancing Sleep Time (REST) program to revolutionize sleep health through objective, home-based, closed-loop technologies that detect and respond to sleep microstructures in real time. The program aims to reduce by at least 50% the 10-year risk of chronic diseases linked to poor sleep—including dementia, depression, cardiovascular disease, and type 2 diabetes—by developing validated systems that measure, diagnose, and treat sleep dysfunction with precision. The technical scope is divided into two areas: Technical Area 1 (TA1) focuses on creating in-home systems for objective measurement and mechanistic classification of poor sleep using physiological signals, while Technical Area 2 (TA2) targets the development of integrated, noninvasive, closed-loop interventions that adapt in real time to individual sleep physiology to improve outcomes. The program is structured into three phased milestones over 66 months—Prove Tech (24 months), Proof-of-Concept (18 months), and Translation (24 months)—with specific technical benchmarks including AUC thresholds for insomnia diagnosis, sensitivity/specificity targets for sleep classification, and Pearson correlation standards for fidelity to polysomnography. Key milestones include IRB approvals by month 3, human subject enrollment by month 12, technology validation and FDA submissions by month 39, and final site visits and demonstrations between months 63 and 66. Proposals must be submitted in two stages: a Solution Summary, due by August 12, 2026, at 12pm ET, and a Full Proposal for those invited to proceed. The Solution Summary must be submitted via https://solutions.arpa-h.gov/events, adhere to strict formatting rules including 12-point Avenir Next LT Pro font, and comply with page limits of six pages for single TA or eight pages for both TAs, excluding cover pages, basis of estimate, cost share strategy, and citations. Only invited proposers may submit a Full Proposal, which includes an in-person pitch—45 minutes for one TA or 60 minutes for both—and supporting documentation divided into five volumes: a four-page Technical Proposal, an unrestricted Cost/Price Proposal, a two-page Human or Animal Subjects Research section, a Data Management and Security Plan, and up to five pages of qualifications per key personnel. Evaluation is based on scientific and technical merit, feasibility, innovation, proposer capability, and budget
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

12 days ago

DEADLINE

in 15 days
View Details
NAICS: 541715
Federal
Technology InteGrator and AcceleratoR (TIGAR)The Technology InteGrator and AcceleratoR (TIGAR) solicitation, issued by the Advanced Research Projects Agency for Health (ARPA-H) under number ARPA-H-SOL-26-144, seeks innovative solutions to enable temperature-flexible storage of complex regenerative tissues and organs, removing reliance on strictly controlled cryogenic conditions. The effort targets functional preservation of organoids, donated tissues, whole organs, or one-cubic-centimeter tissue volumes for at least 30 days at practical temperatures: -80°C, -20°C, 4°C, or 20°C–25°C room temperature, using novel combinations of materials, AI/ML, high-throughput screening, biological interventions, devices, or packaging approaches. The project is structured as an 18-month period of performance divided into two nine-month phases, with a down-select decision at the end of Phase 1. Proposals must align with HHS health IT standards, promote open-source software licensing (MIT, BSD, Apache 2.0), enhance data interoperability, and avoid low-risk or junior-staffed approaches designed solely for cost appearance. Funding is capped at $2 million per award, and only proposals submitted through the ARPA-H Solution Submission Portal will be considered. The solicitation allows multiple Other Transaction (OT) agreements and does not use a set-aside. Submission follows a two-step process: first, a 7-minute Solution Video with a transcript and supplemental slides, and second, a Full Proposal including technical, management, cost, and administrative documentation. The Solution Video deadline for Intake Group 1 has been amended to August 12, 2026, with the Full Proposal deadline extended to September 17, 2026; Intake Group 2 deadlines remain December 8, 2026, and February 5, 2027, respectively. All materials must be submitted via the ARPA-H portal, in English, using sans-serif 11-point fonts, with file names free of spaces or symbols. Evaluation prioritizes scientific and technical merit, proposer capabilities, alignment with ARPA-H’s mission and user needs, and cost realism. Proposal teams must hold valid SAM.gov registrations with active UEIs, provide good faith representations of intellectual property ownership, disclose organizational conflicts of interest, and ensure compliance with federal research security regulations, including prohibitions against involvement with malign foreign talent programs or entities of concern under the CHIPS and
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

15 days ago

DEADLINE

in 6 months
View Details
NAICS: 541715
Federal
Intelligent Generator of Research (IGoR) - ISOThe Intelligent Generator of Research (IGoR) program, issued under solicitation ARPA-H-SOL-26-155 by the Advanced Research Projects Agency for Health (ARPA-H), aims to revolutionize biomedical research by building an AI-enabled interoperable ecosystem that accelerates the development of therapies for complex diseases. Designed as a five-year, three-phase initiative, IGoR seeks to create a closed-loop system comprising mechanistic disease models that capture causal biological relationships across scales, an AI orchestration layer that identifies knowledge gaps and designs optimal experiments, a standardized, reproducible protocol architecture accessible to any qualified lab, and a distributed marketplace of validated laboratories that execute these protocols and return high-quality data. Together, these components aim to produce validated scientific knowledge at least ten times faster than conventional methods, enabling researchers to pursue bold, unconventional directions currently hindered by inefficiency. The program operates under an Other Transaction (OT) Agreement framework governed by a Draft Model OT Agreement, with all terms subject to negotiation by the Government Agreements Officer, and is authorized under 42 U.S.C. § 290c(g)(1)(D). Proposals must fully address four technical areas across all three phases, with Phase III requiring the expansion of the system to a second disease area, operation of a unified experiment marketplace, and public release of all computational artifacts. Proposals must be submitted via the ARPA-H Solutions portal by the extended deadline of August 6, 2026, and must conform to strict formatting guidelines, including English language, 11-point sans-serif font, and 1-inch margins on 8.5 x 11-inch pages. Proposers must register in SAM.gov with an active Unique Entity Identifier (UEI) and designate an Electronic Business Point of Contact, and must include a fully burdened Basis of Estimate covering direct labor, equipment, travel, other direct costs, indirect costs, and profit/fee, with all resource sharing integrated into the total proposed cost. The evaluation will prioritize overall scientific and technical merit, proposer capability, relevance to ARPA-H’s mission, and cost reasonableness, with no fixed weights assigned. Performance is milestone-driven, with payments tied to government verification of successful completion, requiring detailed Task Description Documents (TDDs) specifying quantitative performance criteria. All deliverables must be submitted on schedule and maintained for audit for up to three years post-award. The agreement imposes critical restrictions including prohibition on Covered Telecommunications Equipment under Public Law 115
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

20 days ago

DEADLINE

in 16 days
View Details
NAICS: 541715
Federal
Brain Repair of Any Injured Neural Structure (BRAINS)The Advanced Research Projects Agency for Health (ARPA-H) is seeking innovative solutions through the Brain Repair of Any Injured Neural Structure (BRAINS) Exploratory Topic program under solicitation ARPA-H-SOL-26-148, which utilizes Other Transaction (OT) agreements rather than standard federal contract mechanisms. The program aims to advance technologies capable of restoring function to damaged brain regions—specifically targeting areas such as the hippocampus, amygdala, thalamus, hypothalamus, striatum, cingulate cortex, substantia nigra, brainstem, and cerebellum—by generating and engrafting region-specific precursor tissue, while explicitly excluding the neocortex and spinal cord as well as conventional cell or organoid-based approaches. Proposers must submit a mandatory solution summary prior to full proposal submission, with two intake cycles: the first requiring solution summaries by July 9, 2026, and full proposals by August 6, 2026; the second, with deadlines of January 7, 2027, and February 6, 2027, respectively. Proposals must be submitted via the ARPA-H Solution Submission Portal and must conform to a strict three-volume structure: Volume I (Technical and Management Proposal with a 10-page limit for core content), Volume II (Cost Proposal using the ARPA-H Standard Excel Spreadsheet and supporting narrative), and Volume III (Administrative and Policy Requirements including certifications for organizational conflicts of interest, research security, biosecurity, cyber practices, animal research approvals, and tax compliance). Awardees will be evaluated based on the scientific and technical merit of the approach, the proposer’s expertise, potential for clinical and commercial impact aligned with ARPA-H’s mission, and the reasonableness of the proposed cost, with no preset weighting but ranked in descending importance. Phase I awards are anticipated at $500,000 per team with optional Phase II funding up to an additional $500,000, subject to successful technical milestones and budgetary compliance. Financial administration requires registration and invoice submission via the Payment Management Services (PMS) portal, with detailed justifications for each payment tied to specific milestones or TDD tasks, and salary support for individuals is capped at the Executive Level II rate set by the Office of Personnel Management. All awarded work must occur in the United States, with priority given to domestic entities, and proposers must confirm compliance with national security
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

26 days ago

DEADLINE

in 7 months
View Details